Cyclin D1-positive diffuse large B-cell lymphoma.
Rodriguez-Justo
M
M
Huang
Y
Y
Ye
H
H
Liu
H
H
Chuang
S-S
SS
Munson
P
P
Prada-Puentes
C
C
Kim
I
I
Du
M-Q
MQ
Bacon
C M
CM
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism / Q000473:pathology; D002869:Chromosome Aberrations; D056741:Cyclin D; D016213:Cyclins / Q000378:metabolism*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000032:analysis; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D020522:Lymphoma, Mantle-Cell / Q000175:diagnosis; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor; D056741:Cyclin D; D016213:Cyclins; D004273:DNA, Neoplasm; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone